Week in Review: MID Labs Raises $51 Million From China Investors

MID Labs, a California medical device company that develops novel products for vitreoretinal surgery, closed a $51 million funding from China investors (see story). The investment was led by OrbiMed and Frontline BioVentures, and it included Softbank China Venture Capital (SBCVC), Allen Chao and Sungent BioVenture. The proceeds will be used to continue development of MID Labs' products and increase production capacity in the US and China.

Help employers find you! Check out all the jobs and post your resume.